| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() New JAMA Study Confirms Treating Prostate Cancer Preferable to 'Watchful Waiting' Patients Should Consider All Options, including Minimally Invasive Cryoablation IRVINE, CA -- December 22, 2006 -- Endocare, Inc., an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, announced today that a large study published in the Journal of the American Medical Association (JAMA) this month confirms that men with early prostate cancer should seriously consider all prostate cancer treatment options before choosing "watchful waiting" as a disease management approach. "Watchful waiting" is a concept that suggests patients can wait to see how their disease progresses before undergoing any curative treatments such as surgery or radiation. The JAMA study published December 13, 2006, consisted of 44,630 men between the ages of 65 and 80 and found that those patients who chose to treat their prostate cancer were 30 percent less likely to die than those who waited. This suggests that all patients with localized Endocare President, Chairman and CEO Craig T. Davenport noted, "This study offers further scientific evidence that 'watchful waiting' may not be the best option for many patients, particularly when there are effective, minimally invasive treatments like cryoablation available. Based on the results of the study, 'watchful waiting' patients should consider some kind of treatment. We believe cryoablation is an excellent option for many patients given its proven, long-term cancer control rate, low morbidity, and typically fast recovery time. Cryoablation involves non surgical freezing and destroying of the cancerous tumors using an Endocare Cryocare® System. Recently published 10-year data demonstrated that cryoablation is a viable, effective, safe, durable and many times preferable treatment option
SOURCE: Endocare, Inc.
|